OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
Christina A. Von Roemeling, Bently P. Doonan, Kelena Klippel, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 9, pp. 1751-1762
Open Access | Times Cited: 11
Christina A. Von Roemeling, Bently P. Doonan, Kelena Klippel, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 9, pp. 1751-1762
Open Access | Times Cited: 11
Showing 11 citing articles:
The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases
Yi‐Ru Bai, Weiguang Yang, Xuehui Hou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115606-115606
Closed Access | Times Cited: 21
Yi‐Ru Bai, Weiguang Yang, Xuehui Hou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115606-115606
Closed Access | Times Cited: 21
IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
Ricardo Parrondo, Madiha Iqbal, Reinhard von Roemeling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Ricardo Parrondo, Madiha Iqbal, Reinhard von Roemeling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Modern machine‐learning for binding affinity estimation of protein–ligand complexes: Progress, opportunities, and challenges
Tobias Harren, Torben Gutermuth, Christoph Grebner, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 6
Tobias Harren, Torben Gutermuth, Christoph Grebner, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2024) Vol. 14, Iss. 3
Closed Access | Times Cited: 6
In the era of targeted therapy and immunotherapy: advances in the treatment of large B-cell lymphoma of immune-privileged sites
Haotian Wang, Ying Zhang, Xin Wan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Haotian Wang, Ying Zhang, Xin Wan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
REPORT OF CONSENSUS PANEL 2 FROM THE 12TH INTERNATIONAL WORKSHOP ON THE MANAGEMENT OF BING-NEEL SYNDROME IN PATIENTS WITH WALDENSTROM’S MACROGLOBULINEMIA.
Shayna Sarosiek, Anne-Marie L. Becking, Andrew R. Branagan, et al.
Seminars in Hematology (2025)
Closed Access
Shayna Sarosiek, Anne-Marie L. Becking, Andrew R. Branagan, et al.
Seminars in Hematology (2025)
Closed Access
Targets and treatments in primary CNS lymphoma
Christina A. Von Roemeling, Andrés J.M. Ferreri, Carole Soussain, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 8, pp. 1055-1067
Open Access | Times Cited: 3
Christina A. Von Roemeling, Andrés J.M. Ferreri, Carole Soussain, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 8, pp. 1055-1067
Open Access | Times Cited: 3
Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer
Yifan Feng, Chengjuan Chen, Anqi Shao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5091-5105
Open Access | Times Cited: 3
Yifan Feng, Chengjuan Chen, Anqi Shao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 12, pp. 5091-5105
Open Access | Times Cited: 3
Advances in Primary Central Nervous System Lymphoma
Kate E. Therkelsen, Antonio Omuro
Current Neurology and Neuroscience Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
Kate E. Therkelsen, Antonio Omuro
Current Neurology and Neuroscience Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 1
Novel Agents in Waldenström Macroglobulinemia
Shayna Sarosiek, Jorge J. Castillo
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 4, pp. 751-760
Closed Access | Times Cited: 3
Shayna Sarosiek, Jorge J. Castillo
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 4, pp. 751-760
Closed Access | Times Cited: 3
New hopes in relapsed refractory primary central nervous system lymphoma
Teresa Calimeri, Carolina Steidl, Paolo Del Fiore, et al.
Current Opinion in Oncology (2023) Vol. 35, Iss. 5, pp. 364-372
Closed Access | Times Cited: 3
Teresa Calimeri, Carolina Steidl, Paolo Del Fiore, et al.
Current Opinion in Oncology (2023) Vol. 35, Iss. 5, pp. 364-372
Closed Access | Times Cited: 3
Diagnostic, Pathologic, and Therapeutic Considerations for Primary CNS Lymphoma
Christopher R. D’Angelo
JCO Oncology Practice (2023) Vol. 20, Iss. 2, pp. 195-202
Closed Access
Christopher R. D’Angelo
JCO Oncology Practice (2023) Vol. 20, Iss. 2, pp. 195-202
Closed Access
